Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin outflows resume on Coinbase amid weak U.S. institutional demand and negative premium.

Market News
03 Jul 2026
Tokenpost
View Source
Bearish
pluang ai news

Bitcoin flows on Coinbase Advanced flipped back to net outflows, with a preliminary -571 BTC on July 3, signaling coins moving off-exchange. Despite this, the Coinbase premium remained negative, indicating muted U.S. spot demand as BTC traded cheaper on Coinbase than offshore benchmarks. Institutional trading volume on Coinbase Prime also dropped by 7.2%, suggesting softer large-ticket activity. The mixed signals imply cautious U.S. liquidity conditions, with traders watching for a positive premium and volume rebound to confirm renewed institutional interest.

More News

AI in Pathology market to nearly double by 2035 despite US-Israel-Iran conflict disruptions

AI in Pathology market to nearly double by 2035 despite US-Israel-Iran conflict disruptions

The global AI in Pathology market, valued at $28.75 million in 2025, is projected to grow at a 9.12% CAGR to reach $68.81 million by 2035. Growth is driven by rising demand for digital pathology, AI diagnostics, and improved workflow efficiency throu...

Market News
Neutral
37 minutes ago
AI data centers drive major infrastructure shifts with hyperscalers and sovereign initiatives leading growth.

AI data centers drive major infrastructure shifts with hyperscalers and sovereign initiatives leading growth.

The global AI data center market is rapidly expanding due to the rise of generative AI and advanced cognitive analytics, requiring purpose-built, high-density facilities with advanced cooling and networking technologies. Hyperscalers like Microsoft, ...

Market News
Bullish
38 minutes ago
SKYRIZI sales hit $11.7B in 2024 with 51% growth, expanding across multiple disease indications.

SKYRIZI sales hit $11.7B in 2024 with 51% growth, expanding across multiple disease indications.

SKYRIZI achieved blockbuster sales of $11.7 billion in 2024, growing 51% year-over-year, driven by approvals in psoriasis, psoriatic arthritis, and inflammatory bowel diseases like Crohn's. Its strong clinical efficacy targeting the IL-23 pathway and...

Market News
Bullish
39 minutes ago
Photodynamic therapy market to grow at 8.3% CAGR, reaching $1.53B by 2035 driven by cancer and dermatology uses.

Photodynamic therapy market to grow at 8.3% CAGR, reaching $1.53B by 2035 driven by cancer and dermatology uses.

The global photodynamic therapy (PDT) market is forecasted to grow from $749 million in 2023 to $1.53 billion by 2035, at a CAGR of 8.3%. Growth is fueled by PDT's minimally invasive nature and expanding applications in oncology, dermatology, and ant...

Market News
Bullish
41 minutes ago
Cancer metabolism therapeutics market to grow to $26.3B by 2035, driven by precision medicine and rising cancer cases.

Cancer metabolism therapeutics market to grow to $26.3B by 2035, driven by precision medicine and rising cancer cases.

The cancer metabolism-based therapeutics market is projected to grow from $3.7 billion in 2026 to $26.3 billion by 2035, with a CAGR of 24.3%. This growth is fueled by advances in precision medicine targeting unique cancer cell metabolic pathways, in...

Market News
Bullish
42 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App